CR2

protein-coding

complement C3d receptor 2, the group of CD molecules|Sushi domain containing|Complement system regulators and receptors

Gene summary

This gene encodes a membrane protein, which functions as a receptor for Epstein-Barr virus (EBV) binding on B and T lymphocytes. Genetic variations in this gene are associated with susceptibility to systemic lupus erythematosus type 9 (SLEB9). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]

MANE transcript

NM_001006658.3

Inheritance

AR

ClinVar variants

P:71U:412B:244

Top phenotype

Common variable immune deficiency, 7

gnomAD constraint

pLI —, LoF o/e 0.67

Max pathogenic AF

—

Genomic locus

chr1:207,453,024-207,489,895

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~36.9 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

systemic lupus erythematosusSUPPORTIVE

Inheritance Pattern: Unknown

Disease ID:MONDO:0007915

Submitter: Orphanet

immunodeficiency, common variable, 7DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0013862

Submitter: ClinGen

CR2, also referred to as CD21, was first reported in relation to autosomal recessive common variable immunodeficiency (CVID; OMIM # 614699) in 2012 (Thiel J et al., PMID: 22035880). CR2-associated CVID is a heterogeneous disorder characterized by hypogammaglobulinemia with some patients also presenting with recurrent infections, particularly respiratory infections. Importantly, individuals carrying biallelic pathogenic CR2 variants may present with the immunological phenotype of hypogammaglobulinemia and low levels of class-switched B cells in the absence of a clinical phenotype, such as recurrent infections (PMID: 30075290). It is currently unknown what proportion of affected individuals are currently asymptomatic or how likely they are to present with a clinical phenotype at a later age. Five variants (nonsense, frameshift, and canonical splice site) found that have been reported in three unrelated probands (and four probands total) as either compound heterozygous or homozygous in three publications are included in this curation (PMIDs: 22035880, 26325596, 28499783). The mechanism of pathogenicity appears to be loss of function. This gene-disease association is also supported by animal models, expression studies, and in vitro functional assays (PMIDs: 6234356, 8622941, 8624815, 1702139, 12479818, 22035880, 26325596). CR2 has been shown to be expressed on the majority of circulating mature human B cells and human follicular dendritic cells (PMID: 6234356, 2471772) and is part of the B-cell receptor complex (PMID: 1702139). CD19 (as well as CD81) is also a member of the B-cell receptor complex and has also been associated with common variable immunodeficiency (OMIM # 613493). Mouse models lacking expression of CR2/CR1 have decreased levels of antibody, particularly IgG, and have increased susceptibility to infection (PMIDs: 8622941, 8624815, 12479818). Expression of human CR2 in CR2/CR1-/- mice rescues secondary responses to T-dependent antigen in CR2/CR1-/- mice (PMID: 21269698). B cells from patients with CR2-associated CVID decreased responses to antigen and AID expression (PMIDs: 22035880, 26325596). In summary, CR2 is definitively associated with autosomal recessive CVID. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. Notably, this curation does not assess the reported relationship between CR2 and susceptibility to systemic lupus erythematosus (OMIM # 610927).

immunodeficiency, common variable, 7STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0013862

Submitter: Labcorp Genetics (formerly Invitae)

immunodeficiency, common variable, 7MODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0013862

Submitter: Ambry Genetics

Clinical Genomic Database (CGD)

Common variable immune deficiency, 7AR

Manifestation: Allergy/Immunology/Infectious

Intervention: Allergy/Immunology/Infectious

Rationale: Antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial

Refs: 22035880Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to CR2 variants in ClinVar

9 Conditions Cataloged
Immunodeficiency, common variable, 7Total: 763
Inborn genetic diseasesTotal: 146
not providedTotal: 127
not specifiedTotal: 80
CR2-related disorderTotal: 53
Systemic lupus erythematosus, susceptibility to, 9Total: 20
Immunodeficiency, common variable, 2Total: 9
Joubert syndrome 17Total: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001006658.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
4
clinvar
203
clinvar
4
clinvar
211
missense
3
clinvar
406
clinvar
36
clinvar
1
clinvar
446
nonsense
19
clinvar
12
clinvar
31
start loss
0
frameshift
17
clinvar
9
clinvar
2
clinvar
28
splice donor/acceptor (+/-2bp)
2
clinvar
9
clinvar
11
Total38334122395727

Highest pathogenic variant AF is 0.00088153355

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 17 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001006658.3RefSeqNP_001006659.119MANE Select
ENST00000367057.8EnsemblENSP00000356024.319MANE Select
NM_001877.5RefSeqNP_001868.218Standard
ENST00000367058.7EnsemblENSP00000356025.318Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Complement and coagulation cascades - Homo sapiens (human)
  • B cell receptor signaling pathway - Homo sapiens (human)
  • Hematopoietic cell lineage - Homo sapiens (human)
  • Epstein-Barr virus infection - Homo sapiens (human)
  • B Cell Receptor Signaling Pathway

Biological Process

  • complement receptor mediated signaling pathway
  • immune response
  • complement activation, classical pathway
  • B cell differentiation
  • regulation of complement activation

Molecular Function

  • virus receptor activity
  • complement binding
  • DNA binding
  • complement receptor activity
  • transmembrane signaling receptor activity

Cellular Component

  • plasma membrane
  • integral component of membrane
  • receptor complex
  • extracellular exosome

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000367057
Coding exons
19
Length
35666
Individuals with no LoFs
125652
Homozygous LoFs
0
Heterozygous LoFs
94
Defined
125746
p
0.000374
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.7935425970.9090.00003157113
Missense (PolyPhen)155192.610.804742351
Synonymous-0.5492212111.050.00001122151
Loss of Function2.293856.60.6710.00000334660

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000310.00031rare
Latino/Admixed American0.000200.00020rare
Ashkenazi Jewish0.000100.000099rare
East Asian0.00140.0014notable
Finnish00.0absent
European (Non-Finnish)0.000410.00040rare
South Asian0.000230.00023rare
Other0.000330.00033rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Receptor for complement C3Dd, for the Epstein-Barr virus on human B-cells and T-cells and for HNRNPU (PubMed:7753047). Participates in B lymphocytes activation (PubMed:7753047). {ECO:0000269|PubMed:7753047}.;
Disease
DISEASE: Immunodeficiency, common variable, 7 (CVID7) [MIM:614699]: A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low. {ECO:0000269|PubMed:22035880}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.458

Intolerance Scores

LoFtool
0.952
RVIS EVS
0.06
RVIS percentile EVS
57.56

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.558

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.